These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 20882525
1. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis. Nur E, Mairuhu W, Biemond BJ, van Zanten AP, Schnog JJ, Brandjes DP, Otten HM, CURAMA study group. Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525 [Abstract] [Full Text] [Related]
2. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma. Papatheofanis FJ. J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144 [Abstract] [Full Text] [Related]
3. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812 [Abstract] [Full Text] [Related]
4. Immunoassay for urinary pyridinoline: the new marker of bone resorption. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF. J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991 [Abstract] [Full Text] [Related]
5. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma. Samani KK, Brazier M, Mathiot C, Kamel S, Jamart J, Jaubert J, Blanc M, Azaïs I, Facon T, Leleu X. Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198 [Abstract] [Full Text] [Related]
6. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats. DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS. Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950 [Abstract] [Full Text] [Related]
7. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L. J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254 [Abstract] [Full Text] [Related]
8. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion. Del Campo MT, González-Casaus ML, Aguado P, Bernad M, Carrera F, Martínez ME. Osteoporos Int; 1999 Aug; 9(5):449-54. PubMed ID: 10550465 [Abstract] [Full Text] [Related]
9. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links. Srivastava AK, Libanati C, Oberrauch W, Leenings J, Greenwald M, Baylink DJ. J Bone Miner Metab; 2003 Aug; 21(3):134-44. PubMed ID: 12720047 [Abstract] [Full Text] [Related]
10. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R. J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070 [Abstract] [Full Text] [Related]
11. Bone resorption in anorexia nervosa and rehabilitated patients. Valtueña S, Di Mattei V, Rossi L, Polito A, Cuzzolaro M, Branca F. Eur J Clin Nutr; 2003 Feb; 57(2):260-5. PubMed ID: 12571657 [Abstract] [Full Text] [Related]
12. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study. Seibel MJ, Woitge H, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, Ziegler R, Robins SP. J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828 [Abstract] [Full Text] [Related]
13. Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Rauch F, Schönau E, Woitge H, Remer T, Seibel M. Exp Clin Endocrinol; 1994 Sep; 102(2):94-7. PubMed ID: 8056058 [Abstract] [Full Text] [Related]
14. Markers of bone resorption--measurement in serum, plasma or urine? Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H. Clin Lab; 2003 Sep; 49(5-6):203-7. PubMed ID: 15285175 [Abstract] [Full Text] [Related]
15. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes. Fassbender WJ, Gödde M, Brandenburg VM, Usadel KH, Stumpf UC. Adv Med Sci; 2009 Sep; 54(1):1-6. PubMed ID: 19482729 [Abstract] [Full Text] [Related]
16. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K. J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038 [Abstract] [Full Text] [Related]
17. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. Eastell R, Colwell A, Hampton L, Reeve J. J Bone Miner Res; 1997 Jan; 12(1):59-65. PubMed ID: 9240726 [Abstract] [Full Text] [Related]
18. Bone turnover in malnourished children. Branca F, Robins SP, Ferro-Luzzi A, Golden MH. Lancet; 1997 Jan; 340(8834-8835):1493-6. PubMed ID: 1361595 [Abstract] [Full Text] [Related]
19. Osteocalcin and specific markers of bone resorption in sickle cell disease. Bolarin DM, Azinge EC. Acta Physiol Hung; 2010 Sep; 97(3):290-6. PubMed ID: 20843767 [Abstract] [Full Text] [Related]
20. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. Asaba Y, Hiramatsu K, Matsui Y, Harada A, Nimura Y, Katagiri N, Kobayashi T, Takewaka T, Ito M, Niida S, Ikeda K. Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]